glp-1 glp-2 dual agonist Main physiological actions of the GIP and GLP1 receptor agonist @nejm revisión

The reduction of visceral fat is regarded as one of the non-glucose-lowering effects of GLP-1RAs, such as liraglutide [54], which may contribute to myocardial protection

GLP-1 RAs, such as exenatide and lixisenatide, have shown benefits in addressing the pathology of PD in animal studies and phase II clinical trials, halting progression and delaying worsening of symptoms

The complex biotechnological manufacturing of peptide-based therapies, which requires sophisticated facilities and lengthy production timelines, makes rapid scaling a logistical challenge

Methylcobalamin is an active, highly bioavailable form of B12 that supports energy metabolism and nerve function, both of which can be affected during periods of significant dietary change

A., Stein C., et al., Do GLP1 Receptor Agonists Increase the Risk of Breast Cancer

The SELECT trial demonstrated a 20% lower rate of fatal and non-fatal cardiovascular events among people who were overweight or obese with a history of cardiovascular disease but not diabetes